← FDA Drug Approvals (Drugs@FDA)

BACITRACIN ZINC AND POLYMYXIN B SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 1995-01-30

Drug application

FDA Application #
ANDA064028
Application type
Abbreviated New Drug Application (Generic)
Brand name
BACITRACIN ZINC AND POLYMYXIN B SULFATE
Generic name
Bacitracin Zinc
Active ingredients
BACITRACIN ZINC; POLYMYXIN B SULFATE
Dosage form
OINTMENT
Route
OPHTHALMIC
Marketing status
Discontinued
Sponsor
SCIEGEN PHARMS
First approval
1995-01-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown